W

WuXi Biologics (Cayman)
2269

Last Price

Financial Snapshot

gainify

Market Data

Market Cap
HK$113.92B
EV
HK$111.68B
Shares Outstanding
4.21B
Beta
0.55

Wall Street View

Analyst Rating
OUTPERFORM
Analyst Target Price
HK$26.77
P/E 2025E
23.59x
P/Revenue 2025E
4.91x

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About WuXi Biologics (Cayman) Inc.

gainify

W

WuXi Biologics (Cayman) Inc.

2269

WuXi Biologics (Cayman) Inc., an investment holding company, provides end-to-end solutions and services for biologics discovery, development, and manufacturing for biologics industry in the People’s Republic of China, North America, Europe, Singapore, Japan, South Kor...

Sector

Healthcare

Industry

Biotechnology

CEO

Chen, Zhisheng

Employees

12,575

IPO Date

2017-06-13

Headquarters

No. 108, Meiliang Road, Mashan, Wuxi, Jiangsu Province, 214092, China

gainify
Send us an emailFollow us on XConnect with us on LinkedInFollow us on InstagramFollow us on ThreadsCheck us out on Trustpilot
powered-by-sp

Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2025, S&P Global Market Intelligence. All rights reserved.

View Data Providers

NEWSLETTER

Gainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.

© 2025 Gainify. All rights reserved.